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Is it time to loosen the restrictions 
on athletes with cardiac disorders 
competing in sport?
Rui Providência,1 Carina Teixeira,2 Oliver Segal,1 Augustus Ullstein,3 
Kim T Mueser,2 Pier Lambiase1
Sudden cardiac death (SCD) in young 
athletes is a rare and dramatic event. Initial 
consensus guidelines from 2005 recom-
mend restriction from competitive sports 
for all athletes with hereditary cardiomy-
opathies and channelopathies, with very 
minor exceptions.1
The fIeld has changed: new daTa 
supporT a new approach
After decades of a conservative sports 
cardiology approach, recent findings 
call these universal restrictions into 
question. First, data on the use of auto-
matic external defibrillators (AEDs) for 
witnessed sudden cardiac arrest (SCA) in 
sports have been reassuring.2 When SCA is 
properly recognised and an AED immedi-
ately available, survival from SCA during 
sport is largely possible.
Second, two reports, one focusing 
on long QT syndrome in athletes,3 and 
another on catecholaminergic ventric-
ular tachycardia,4 have suggested that the 
risk of competition may be acceptable 
if athletes are well-informed and fully 
compliant with therapy. A recent task 
force of the American Heart Association 
and American College of Cardiology has 
suggested that competitive sports prac-
tice may be permissible in some athletes 
with channelopathies, assuming that 
appropriate precautionary measures are 
in place. Specifically, avoidance of exac-
erbating drugs, avoidance of dehydration, 
appropriate electrolyte replenishment 
(with drinks containing Mg2+ and K+) 
and establishment of an emergency action 
plan with staff trained in cardiopulmonary 
resuscitation and access to an AED.5
Third, in a recently analysis of 184 
consecutive deaths in patients with 
hypertrophic cardiomyopathy referred 
to a single cardiac pathology centre, the 
authors observed that 81% of deaths 
occurred at rest, unrelated to exertion.6 In 
most cases of sudden death on exertion, 
a diagnosis was missed during life. These 
data suggest that diagnosing these individ-
uals before a final ventricular arrhythmia 
occurs is of utmost importance, as it may 
allow the implementation of effective 
preventive measures, such as implantable 
cardioverter defibrillators (ICDs).
Fourth, our understanding of athletes 
with ICDs has progressed from data 
provided by the ICD Sports Safety Registry. 
In this multicentre, multinational registry 
no major adverse events (tachyarrhythmic 
death, externally resuscitated tachyar-
rhythmia during or after sports or severe 
injury resulting from arrhythmia-related 
syncope or shock during sports) were 
observed, suggesting that athletes can 
take part in sports without serious injury 
or failure of the ICD to terminate the 
arrhythmia.7
After following the trajectory of thou-
sands of disqualified athletes over the 
years, we now realise that we lacked 
knowledge about the natural history 
of these disease entities and that old 
recommendations1 were overcautious, as 
competitive sports might, after all, not 
cause a major cardiovascular event in all 
these individuals.
This understanding should prompt us to 
shift to a more balanced, but still cautious, 
approach when dealing with potential 
disqualification decisions in athletes with 
identified cardiac disorders.
TIme for aThleTe empowermenT
Over the past few decades, medicine 
in general has become more open to 
enabling the participation of patients in 
decisions about the diagnosis and treat-
ment of their conditions, a concept 
known as ‘empowerment’, which is 
being implemented more widely.8 A step 
forward with regard to cardiac disorders 
includes empowerment and shared deci-
sion-making, with placement of the athlete 
in a central role for planning their future.
Accordingly, we believe that it is the 
responsibility of the physician to inform 
athletes about the disease, natural history, 
treatment options, areas of uncertainty, 
and to assist them in making their deci-
sion based on their own values, and the 
underlying estimated risk of SCD. Can 
we deny these athletes the right to expose 
themselves to a small and uncertain risk 
that can be substantially reduced in most 
circumstances by AEDs, ICDs or medica-
tion, while we accept the risks of death or 
traumatic brain injury in motor sports and 
contact sports such as boxing/kick boxing, 
American football and rugby?
cardIac dIsorders and 
conTracTual Issues
A special situation occurs for team physi-
cians. Even though physicians employed 
by teams should still have the same 
empowering approach and obligations 
towards the athlete/patient, additional 
complexity and ethical issues arise when 
treating athletes finalising a financial 
contract. The team physician is obliged 
in his/her role to provide information to 
the team management about the athlete’s 
health status. Accordingly, management 
may be concerned about the risk of SCD 
and the effect on their club, the possibility 
of disease progression such that the athlete 
needs to abandon sports, or the potential 
impact on the transfer fee if trying to nego-
tiate with another club. If this occurs and 
the club aborts the signing of a contract, 
assuming the athlete is willing to compete, 
he/she will have to find a sports club who 
accepts the potential risks of the cardiac 
problem. It is ultimately up to the manage-
ment to decide whether or not they accept 
hiring of the athlete. However, it should 
be up to the athlete—not the physician—
whether they want to compete after being 
informed of the risk.
In conclusion, we believe this emerging 
evidence indicates that for many cardiac 
conditions the time has now come for 
sports cardiologists and team physicians 
to abandon a paternalistic approach and 
involve athletes in the decision-making 
process. After all, it is their lives and goals 
we are deciding, and to a certain point 
this can be considered a matter of free will 
and human rights. This should ideally be 
formalised in an informed consent process 
between the physician, athlete and sports 
team, outlining the known and unknown 
risks and recording that the athlete is 
making a fully informed decision to 
compete.
contributors RP and CT identified & proposed 
the need for the empowerment in this setting and 
wrote the first draft of the manuscript, which was 
1Barts Heart Centre, Cardiac Electrophysiology 
Department, St. Bartholomew’s Hospital, Barts NHS 
Trust, London, UK
2Center for Psychiatric Rehabilitation, Boston University, 
Boston, Massachusetts, USA
3Thirty Nine Essex Street LLP, London, UK
correspondence to Dr Rui Providência, Barts 
Heart Centre, Cardiac Electrophysiology Department, 
St. Bartholomew’s Hospital, Barts NHS Trust, West 
Smithfield, London EC1A 7BE, UK;  
 rui_ providencia@ yahoo. com
editorial
group.bmj.com on June 28, 2017 - Published by http://bjsm.bmj.com/Downloaded from 
1057Providência R, et al. Br J Sports Med July 2017 Vol 51 No 14
editorial
thoroughly revised by PL and OS. A second draft of 
the manuscript was then prepared and discussed 
with AW who provided legal advice and suggested 
areas of improvement and KM who gave advice 
on empowerment issues. The final version of the 
manuscript was revised by all authors, and approved 
before submission.
funding CT was funded by the Advanced 
Rehabilitation Research Training program (Grant 
♯90AR5018) of the National Institute on Disability 
Independent Living and Rehabilitation Research 
(NIDILRR), housed within the Agency for Community 
Living (ACL) at the Department of Health and Human 
Services (HHS). The contents of this project do not 
necessarily represent the policy of NIDILRR, ACL, HHS, 
and you should not assume endorsement by the US 
Federal Government. PL was supported by University 
College of London Hospitals Biomedicine Research 
Centre, a Partnership between University College of 
London and University College of London Hospitals 
NHS Trust, funded by the National Institute for Health 
Research (NIHR); British Heart Foundation. 
competing interests None declared.
provenance and peer review Not commissioned; 
externally peer reviewed.
open access This is an Open Access article 
distributed in accordance with the Creative Commons 
Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build 
upon this work non-commercially, and license their 
derivative works on different terms, provided the 
original work is properly cited and the use is non-
commercial. See: http:// creativecommons. org/ licenses/ 
by- nc/ 4.0/
© Article author(s) (or their employer(s) unless 
otherwise stated in the text of the article) 2017. All 
rights reserved. No commercial use is permitted unless 
otherwise expressly granted.
To cite Providência R, Teixeira C, Segal O, 
et al. Br J Sports Med 2017;51:1056–1057.
Revised 20 February 2017
Accepted 27 March 2017
Published Online First 28 April 2017
Br J Sports Med 2017;51:1056–1057.
doi:10.1136/bjsports-2016-097002
RefeRences
1 Pelliccia A, Fagard R, Bjørnstad HH, et al; Study 
Group of Sports Cardiology of the Working Group 
of Cardiac Rehabilitation and Exercise Physiology, 
Working Group of Myocardial and Pericardial 
Diseases of the European Society of Cardiology. 
Recommendations for competitive sports 
participation in Athletes with cardiovascular disease: 
a consensus document from the study group of 
sports cardiology of the working group of cardiac 
rehabilitation and exercise physiology and the 
working group of myocardial and pericardial diseases 
of the european society of cardiology. Eur Heart J 
2005;26:1422–45.
2 Drezner JA, Toresdahl BG, Rao AL, et al. Outcomes 
from sudden cardiac arrest in US high schools: a 2-year 
prospective study from the national registry for AED use 
in sports. Br J Sports Med 2013;47:1179–83.
3 Aziz PF, Sweeten T, Vogel RL, et al. Sports participation 
in genotype positive children with long QT syndrome. 
JACC Clin Electrophysiol 2015;1:62–70.
4 Ostby SA, Bos JM, Owen HJ, et al. Competitive sports 
participation in patients with catecholaminergic 
polymorphic ventricular tachycardia: a single 
center’s early experience. JACC Clin Eelectrophysiol 
2016;2:253–62.
5 Ackerman MJ, Zipes DP, Kovacs RJ, et al; American 
Heart Association Electrocardiography and Arrhythmias 
Committee of Council on Clinical Cardiology, Council 
on Cardiovascular Disease in Young, Council on 
Cardiovascular and Stroke Nursing, Council on 
Functional Genomics and Translational Biology, 
and American College of Cardiology. Eligibility and 
disqualification recommendations for competitive 
athletes with cardiovascular abnormalities: task force 
10: the cardiac channelopathies: a scientific statement 
from the American Heart Association and American 
College of Cardiology. Circulation 2015;132:e326–9.
6 Finocchiaro G, Papadakis M, Dhutia H. Circumstances 
of sudden death in hypertrophic  cardiomyopathy. 
data from a large pathology registry. Eur Heart J 
2016;37:1226–7.
7 Lampert R, Olshansky B, Heidbuchel H, et al. Safety 
of sports for athletes with implantable cardioverter-
defibrillators: results of a prospective, multinational 
registry. Circulation 2013;127:2021–30.
8 Pulvirenti M, McMillan J, Lawn S, Empowerment 
LS. Empowerment, patient centred care and self-
management. Health Expect 2014;17:303–10.
group.bmj.com on June 28, 2017 - Published by http://bjsm.bmj.com/Downloaded from 
sport?
athletes with cardiac disorders competing in 
Is it time to loosen the restrictions on
Mueser and Pier Lambiase
Rui Providência, Carina Teixeira, Oliver Segal, Augustus Ullstein, Kim T
doi: 10.1136/bjsports-2016-097002
2017
2017 51: 1056-1057 originally published online April 28,Br J Sports Med 
 http://bjsm.bmj.com/content/51/14/1056
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bjsm.bmj.com/content/51/14/1056
This article cites 8 articles, 5 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on June 28, 2017 - Published by http://bjsm.bmj.com/Downloaded from 
